NM_005670.4:c.148G>C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_005670.4(EPM2A):​c.148G>C​(p.Gly50Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000831 in 1,204,006 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G50W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000068 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000085 ( 1 hom. )

Consequence

EPM2A
NM_005670.4 missense

Scores

2
5
11

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.706

Publications

1 publications found
Variant links:
Genes affected
EPM2A (HGNC:3413): (EPM2A glucan phosphatase, laforin) This gene encodes a dual-specificity phosphatase and may be involved in the regulation of glycogen metabolism. The protein acts on complex carbohydrates to prevent glycogen hyperphosphorylation, thus avoiding the formation of insoluble aggregates. Loss-of-function mutations in this gene have been associated with Lafora disease, a rare, adult-onset recessive neurodegenerative disease, which results in myoclonus epilepsy and usually results in death several years after the onset of symptoms. The disease is characterized by the accumulation of insoluble particles called Lafora bodies, which are derived from glycogen. [provided by RefSeq, Jan 2018]
EPM2A-DT (HGNC:48990): (EPM2A divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.31423646).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPM2ANM_005670.4 linkc.148G>C p.Gly50Arg missense_variant Exon 1 of 4 ENST00000367519.9 NP_005661.1 O95278-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPM2AENST00000367519.9 linkc.148G>C p.Gly50Arg missense_variant Exon 1 of 4 1 NM_005670.4 ENSP00000356489.3 O95278-1

Frequencies

GnomAD3 genomes
AF:
0.00000684
AC:
1
AN:
146190
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000151
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000238
AC:
1
AN:
41974
AF XY:
0.0000392
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000578
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000851
AC:
9
AN:
1057816
Hom.:
1
Cov.:
34
AF XY:
0.00000969
AC XY:
5
AN XY:
516144
show subpopulations
African (AFR)
AF:
0.0000992
AC:
2
AN:
20162
American (AMR)
AF:
0.00
AC:
0
AN:
12196
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12534
East Asian (EAS)
AF:
0.00
AC:
0
AN:
14704
South Asian (SAS)
AF:
0.0000419
AC:
2
AN:
47730
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
16214
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2586
European-Non Finnish (NFE)
AF:
0.00000448
AC:
4
AN:
893200
Other (OTH)
AF:
0.0000260
AC:
1
AN:
38490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000684
AC:
1
AN:
146190
Hom.:
0
Cov.:
33
AF XY:
0.0000140
AC XY:
1
AN XY:
71204
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40652
American (AMR)
AF:
0.00
AC:
0
AN:
14736
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4718
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4350
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9086
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.0000151
AC:
1
AN:
66020
Other (OTH)
AF:
0.00
AC:
0
AN:
2038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.030
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
14
DANN
Uncertain
0.97
DEOGEN2
Benign
0.38
T;.;.;.
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.68
T;T;.;T
M_CAP
Pathogenic
0.90
D
MetaRNN
Benign
0.31
T;T;T;T
MetaSVM
Uncertain
0.19
D
MutationAssessor
Benign
0.90
L;L;L;L
PhyloP100
0.71
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-0.72
N;.;.;.
REVEL
Uncertain
0.30
Sift
Uncertain
0.024
D;.;.;.
Sift4G
Uncertain
0.032
D;D;.;.
Polyphen
0.0050
B;P;P;.
Vest4
0.15
MutPred
0.34
Gain of methylation at G50 (P = 0.0175);Gain of methylation at G50 (P = 0.0175);Gain of methylation at G50 (P = 0.0175);Gain of methylation at G50 (P = 0.0175);
MVP
0.92
MPC
0.33
ClinPred
0.20
T
GERP RS
2.5
PromoterAI
0.087
Neutral
gMVP
0.44
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs753397854; hg19: chr6-146056487; API